C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes
Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer
Small Cell Lung Cancer Classification:
Unraveling Heterogeneity to Enable Personalized Treatments
Small Particles, Big Problems: Polystyrene nanoparticles induce DNA damage, oxidative stress,migration, and mitogenic pathways predominantly in non-malignant lung cells:
Deep Learning-Based Retinoblastoma Protein Subtyping of
Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin-Stained Specimens
Comparative profiling of surgically resected primary tumors and
their lymph node metastases in small-cell lung cancer